Kate N McKereghan

Title: The Innovative Contributions of Kate N McKereghan

Introduction

Kate N McKereghan is a prominent inventor based in Seattle, WA. She has made significant contributions to the field of biotechnology, particularly in the area of interleukin-2 research. With a total of 2 patents, her work has advanced the understanding and application of this important cytokine.

Latest Patents

McKereghan's latest patents include a process for preparing bovine interleukin-2 and DNA sequences encoding bovine interleukin-2. The first patent describes a method for culturing a microbial host transformed by a vector containing a DNA sequence encoding bIL-2. This process allows for the expression and recovery of bIL-2, which is crucial for various therapeutic applications. The second patent involves the use of a chemically-synthesized oligonucleotide as a probe to isolate the gene coding for human IL-2. This innovative approach utilizes double-stranded cDNA prepared from bovine cells to express recombinant bovine IL-2 in yeast and bacterial systems.

Career Highlights

Throughout her career, McKereghan has worked with notable companies, including Immunex Corporation. Her expertise in biotechnology has positioned her as a key figure in the development of therapeutic proteins.

Collaborations

Some of her notable coworkers include Dirk M Anderson and Paul E Baker. Their collaborative efforts have contributed to the advancement of research in the field of interleukin-2.

Conclusion

Kate N McKereghan's innovative work in biotechnology, particularly her patents related to bovine interleukin-2, showcases her significant contributions to the field. Her collaborations and career highlights further emphasize her impact on scientific research and development.